In 2022, Lynn Tetrault earned $2.02M in total compensation at NeoGenomics, including $391.18K salary, $1.50M bonus and $126.00K in stock. Most recently sold 6,112 shares in Mar 2024. Currently holds stock worth $1.60M.
Compensation History
Annual executive compensation data for Lynn Tetrault, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$2.02M
Salary
$391.18K
Bonus
$1.50M
Other
$0.00
Salary
$391.18KBoard Justification
The compensation philosophy is focused on providing competitive compensation and benefits that attract, retain, and motivate highly skilled management, aligning with stockholder interests.
Bonus
$1.50MBoard Justification
Awarded based on key progress associated with operational effectiveness, business growth, and new executive leadership.
Other Compensation
$0.00Board Justification
No significant perquisites or personal benefits provided.
Restricted Stock
Board Justification
Restricted stock awards granted on June 10, 2022, vesting on June 10, 2023.
Performance Metrics
Performance metrics include operational effectiveness, business growth, and new executive leadership.
Lynn Tetrault
Ex-CEO of NeoGenomics
Sector of Economy
Healthcare
CEO of NeoGenomics for
0 years 0 months (Aug 2022 - Aug 2022)
Previous Experience
Unknown
Other NeoGenomics CEOs
Holdings
Track Lynn Tetrault's stock holdings and portfolio value over time.
Total Stock Sold
$387.26K
$387.26K
24,112 NEO shares
What if they kept their stock?
If Lynn Tetrault didn't sell their stock, today they would have:
Extra NEO24,112 shares worth $282.35K.
This is -27.09% and $104.91K less than what they got when they sold the stock.
Insider Trading
Lynn Tetrault's recent stock transactions, purchases, and sales filed with the SEC.
$97.58K
NEO at $15.97/share
Mar 4, 2024
Sale
15,556 shares
NEO
Jun 10, 2022
Received
838 shares
NEO
Oct 11, 2021
Received
3,081 shares
NEO
Jun 2, 2021
Received
2,698 shares
NEO
May 28, 2020
Received
3,419 shares
NEO
Jun 6, 2019
Received
$207.81K
NEO at $15.99/share
Nov 19, 2018
Sale
Rivals
Compare Lynn Tetrault with competitor CEOs and industry peers.